Novavax (NVAX)
(Real Time Quote from BATS)
$13.84 USD
+0.83 (6.38%)
Updated May 20, 2024 11:34 AM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/13/24 |
---|---|
Current Quarter | -0.87 |
EPS Last Quarter | -1.05 |
Last EPS Surprise | -0.96% |
ABR | 2.00 |
Earnings ESP
|
7.16% |
---|---|
Current Year | -0.61 |
Next Year | 0.33 |
EPS (TTM) | -3.17 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 196.63M | 76.71M | 919.61M | 686.18M |
# of Estimates | 4 | 5 | 2 | 5 |
High Estimate | 531.60M | 103.70M | 1.03B | 1.20B |
Low Estimate | 75.00M | 41.80M | 810.12M | 49.73M |
Year ago Sales | 424.43M | 186.99M | 983.71M | 919.61M |
Year over Year Growth Est. | -53.67% | -58.98% | -6.52% | -25.38% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.87 | -0.79 | -0.61 | 0.33 |
# of Estimates | 4 | 5 | 5 | 7 |
Most Recent Consensus | -0.92 | -1.06 | -1.40 | -0.16 |
High Estimate | -0.53 | -0.58 | 0.13 | 5.67 |
Low Estimate | -1.23 | -1.06 | -1.40 | -2.18 |
Year ago EPS | 0.58 | -1.26 | -5.41 | -0.61 |
Year over Year Growth Est. | -250.00% | 37.30% | 88.72% | 154.99% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 1 | 1 | 2 |
Up Last 30 Days | 0 | 1 | 1 | 2 |
Up Last 60 Days | 1 | 1 | 2 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 1 | 1 | 2 |
Down Last 60 Days | 0 | 1 | 1 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.87 | -0.79 | -0.61 | 0.33 |
7 Days Ago | -0.87 | -0.81 | -0.87 | -0.32 |
30 Days Ago | -0.87 | -0.80 | -0.87 | -0.07 |
60 Days Ago | -0.90 | -0.65 | -0.74 | 0.34 |
90 Days Ago | -0.99 | -0.52 | -0.56 | 0.20 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.81 | -0.82 | -0.76 | 0.46 |
Zacks Consensus Estimate | -0.87 | -0.79 | -0.61 | 0.33 |
Earnings ESP | 7.16% | -3.54% | -22.96% | 37.28% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.05 | -1.44 | -1.26 | 0.58 | NA |
Estimate | -1.04 | -0.49 | -1.82 | -1.24 | NA |
Difference | -0.01 | -0.95 | 0.56 | 1.82 | 0.36 |
Surprise | -0.96% | -193.88% | 30.77% | 146.77% | -4.33% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more